Skip to contentSchranz Jennifer — Nabriva Therapeutics AG insider: 21 transactions · InsiderLensInsider trading activity of Schranz Jennifer
- Transactions on record
- 21
- since Apr 3, 2018
- Open-market buys
- 1
- $20.5K
- Open-market sells
- 0
- Companies traded
- 1
- last filing Mar 2, 2021
Figures computed from official regulatory filings — methodology.
Companies where Schranz Jennifer has traded
Track record of Schranz Jennifer
Insufficient history for a statistical track record (fewer than 5 open-market buys).
Transaction history of Schranz Jennifer
Co-insiders of Schranz Jennifer
This page republishes public regulatory disclosures. Concerned by this data? Exercise your right to object →
Dolan DanNabriva Therapeutics AG
| Company | Filed | Type | Qty | Price | Value · USD | Src |
|---|
| Mar 2, 2021 | Other | -33 | 2.39 USD | $78.9 | SEC |
| Feb 2, 2021 | Award | 22,500 | 0.00 USD | $0 | SEC |
| Feb 2, 2021 | Other | -36 | 2.62 USD | $94.3 | SEC |
| Jan 5, 2021 | Other | -30 | 2.42 USD | $72.6 | SEC |
| Dec 1, 2020 | Other | -301 | 0.43 USD | $129.4 | SEC |
| Nov 2, 2020 | Other | -301 | 0.50 USD | $150.5 | SEC |
| Oct 1, 2020 | Other | -301 | 0.53 USD | $159.5 | SEC |
| Sep 2, 2020 | Other | -301 | 0.62 USD | $186.6 | SEC |
| Aug 4, 2020 | Other | -301 | 0.76 USD | $228.8 | SEC |
| Jul 2, 2020 | Other | -301 | 0.67 USD | $201.7 | SEC |
| Jun 3, 2020 | Other | -301 | 1.14 USD | $343.1 | SEC |
| May 4, 2020 | Other | -301 | 0.55 USD | $165.6 | SEC |
| Apr 2, 2020 | Other | -301 | 0.58 USD | $174.6 | SEC |
| Mar 3, 2020 | Other | -301 | 1.35 USD | $406.4 | SEC |
| Feb 10, 2020 | Award | 105,000 | 0.00 USD | $0 | SEC |
| Feb 10, 2020 | AwardD | 210,000 | 0.00 USD | $0 | SEC |
| Feb 4, 2020 | Other | -4,295 | 1.35 USD | $5.8K | SEC |
| Feb 4, 2019 | AwardD | 235,000 | 0.00 USD | $0 | SEC |
| Feb 4, 2019 | AwardD | 52,500 | 0.00 USD | $0 | SEC |
| Jun 25, 2018 | Buy | 5,500 | 3.73 USD | $20.5K | SEC |
| Apr 3, 2018 | AwardD | 150,000 | 0.00 USD | $0 | SEC |